Member Info for itsallamess

Well this is new.

The Naz is on 3. 50 euros. Which is £3. 17

This is the first time I've seen us over on AIM at a high Share price at £3.28

328
Looking good

Math

Excellent find.. Published today.

Completely backs up what faron have been saying about Traumakine

Oil, I thought the same thing

https://www.proactiveinvestors.co.uk/companies/news/215244/faron-pharma-right-in-middle-of-fight-against-cancer-and-coronavirus-215244.html

News on interferon manufacturing with the 2 mill loan?

Would be great for some news this week.
Who is paying for hibiscus is on the cards?
Any results from WHO and Remap?
Clevegen enrolment?

Thanks oil

So interferon is still in the game.

They cant really say too much

Seem to recall on a interview a couple of months ago Marku saying they had enough Traumakine for the whole of Finland.

Circa 5.5 million population

If I recall we had this discussion a while back on this bb

Can the cfo buy during a closed period?

Our CFO is part of the upper management but he isn't on the board of directors.

Directors can't buy during a closed period. It could be a loop hole thing where he CN get away with it.

Either I don't think we are in a closed period. Any WHO info is out of Faron hands, it's a seperate trial.

Also hibiscus is already announced.
Clevegen is in the recruitment stage.

Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces today that the Company will donate supplies of its investigational intravenous (IV) interferon (IFN) beta-1a for 2,000 patients in the World Health Organization's (WHO) Solidarity trial investigating potential COVID-19 treatments.



Dr. Markku Jalkanen, Faron's CEO, said: "We are pleased that the WHO has included IFN beta-1a on its list of priority drugs to be tested against COVID-19, especially the IV form of the drug, which is what we believe critically ill patients need.

Check the rns out. We are in for 2000 treatments of Traumakine,
It's not 2000 doses of interferon to be used any old way.

https://twitter.com/KariTikkinen/status/1261955252884049922?s=19

Marku said when he gave the interview after the RNS saying we are involved with WHO solidarity that it's out of Faron hands what happens.

Doctors can choice what medications to use and as results come in then different arms can be discontinued.

I suspect that faron has some inside info/a good idea how things are progressing but as far as final results we will have to wait.

All we know is that there are 2000 treatments out there that are up for grabs. Whether they are used on their own or in combinations with the other drugs we will won't know u till the end.

I doubt frin will tell you any more than that

Yea it's TRUE

8 lots of 5000 shares today. There wont ge anything left on AIM to buy soon

Ted

If you haven't already done so watch the last 2 or 3 video interviews
http://www.faron.com/news-events/media/videos

Oil I agree

Something else to think about.

Who solidarity has culled the drugs that don't work. Presuming all were giving the same amount of attention by doctors, there must be some results not yet declared to us that the remaining drugs work

Or

The ones that have just been chucked out were given an advantage but now proven useless we now have a more level playing field

I get the feeling Traumakine is the underdog in this race but still showed enough promise to be added into a very limited WHO drug trial.

Think we may be in for a cracking RNS soon

From one of the recent interviews Marku corrected Andrew Scott when he said 'you have given 2000 doses of interferon beta and markuu replied' 2000 treatments'

That to me is significant because there will be a record of a treatment course of Traumakine given to patients so we will see at some point the difference between injection and iv

this now leaves just two drugs still approved for testing.

These include remdesivir, which was previously tested as an Ebola treatment; and interferon beta-1a, which is used for the treatment of multiple sclerosis

https://www.siliconrepublic.com/innovation/who-hydroxychloroquine-lopinavir-ritonavir-solidarity-trial

5 paragraphs frin the bottom